Cargando…
Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828397/ https://www.ncbi.nlm.nih.gov/pubmed/24209891 http://dx.doi.org/10.1186/1752-153X-7-175 |
_version_ | 1782291241598189568 |
---|---|
author | Munigunti, Ranjith Gathiaka, Symon Acevedo, Orlando Sahu, Rajnish Tekwani, Babu Calderón, Angela I |
author_facet | Munigunti, Ranjith Gathiaka, Symon Acevedo, Orlando Sahu, Rajnish Tekwani, Babu Calderón, Angela I |
author_sort | Munigunti, Ranjith |
collection | PubMed |
description | BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant (W2) strains of Plasmodium falciparum through an in vitro assay and also for analysis of non-covalent interactions with P. falciparum thioredoxin reductase (PfTrxR) through in silico docking studies. RESULTS: The inhibitors of PfTrxR namely, 1,4-NQ, 4-NBT and MD displayed significant antimalarial activity with IC(50) values of < 20 μM and toxicity against 3T3 cell line. 2,4-DNPS was only moderately active. In silico docking analysis of these compounds with PfTrxR revealed that 2,4-DNPS, 4-NBT and MD interact non-covalently with the intersubunit region of the enzyme. CONCLUSIONS: In this study, tools for the identification of PfTrxR inhibitors using phenotyphic screening and docking studies have been validated for their potential use for antimalarial drug discovery project. |
format | Online Article Text |
id | pubmed-3828397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38283972013-11-15 Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques Munigunti, Ranjith Gathiaka, Symon Acevedo, Orlando Sahu, Rajnish Tekwani, Babu Calderón, Angela I Chem Cent J Research Article BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant (W2) strains of Plasmodium falciparum through an in vitro assay and also for analysis of non-covalent interactions with P. falciparum thioredoxin reductase (PfTrxR) through in silico docking studies. RESULTS: The inhibitors of PfTrxR namely, 1,4-NQ, 4-NBT and MD displayed significant antimalarial activity with IC(50) values of < 20 μM and toxicity against 3T3 cell line. 2,4-DNPS was only moderately active. In silico docking analysis of these compounds with PfTrxR revealed that 2,4-DNPS, 4-NBT and MD interact non-covalently with the intersubunit region of the enzyme. CONCLUSIONS: In this study, tools for the identification of PfTrxR inhibitors using phenotyphic screening and docking studies have been validated for their potential use for antimalarial drug discovery project. BioMed Central 2013-11-10 /pmc/articles/PMC3828397/ /pubmed/24209891 http://dx.doi.org/10.1186/1752-153X-7-175 Text en Copyright © 2013 Munigunti et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Munigunti, Ranjith Gathiaka, Symon Acevedo, Orlando Sahu, Rajnish Tekwani, Babu Calderón, Angela I Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title | Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title_full | Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title_fullStr | Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title_full_unstemmed | Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title_short | Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques |
title_sort | characterization of pftrxr inhibitors using antimalarial assays and in silico techniques |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828397/ https://www.ncbi.nlm.nih.gov/pubmed/24209891 http://dx.doi.org/10.1186/1752-153X-7-175 |
work_keys_str_mv | AT muniguntiranjith characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques AT gathiakasymon characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques AT acevedoorlando characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques AT sahurajnish characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques AT tekwanibabu characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques AT calderonangelai characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques |